The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $13.10

Today's change+0.25 +1.95%
Updated March 1 3:37 PM EST. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $13.10

Today's change+0.25 +1.95%
Updated March 1 3:37 PM EST. Delayed by at least 15 minutes.

Meridian Bioscience Inc Hits New 20-day High

Meridian Bioscience Inc is up sharply today, rallying (U.S.)$0.25 or 1.95% to (U.S.)$13.10 and setting a new 20-day high. Over the last five days, shares have gained 4.80%, but are down 25.99% for the last year to date. Shares have underperformed the S&P 500 by 57.61% during the last year.

Key company metrics

  • Open(U.S.) $12.90
  • Previous close(U.S.) $12.85
  • High(U.S.) $13.18
  • Low(U.S.) $12.85
  • Bid / Ask(U.S.) $13.05 / (U.S.) $13.10
  • YTD % change-25.99%
  • Volume381,011
  • Average volume (10-day)499,624
  • Average volume (1-month)624,636
  • Average volume (3-month)421,651
  • 52-week range(U.S.) $10.75 to (U.S.) $21.49
  • Beta0.99
  • Trailing P/E18.78×
  • P/E 1 year forward19.52×
  • Forward PEG1.15×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield3.82%
  • Trailing EPS(U.S.) $0.70
Updated March 1 3:37 PM EST. Delayed by at least 15 minutes.
S&P TSX1.35%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue47475151
Total other revenue--------
Total revenue47475151
Gross profit29303334
Total cost of revenue17171818
Total operating expense37383736
Selling / general / administrative16161615
Research & development3443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--10--
Other operating expenses, total--------
Operating income1091415
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1091315
Income after tax6599
Income tax, total3356
Net income6599
Total adjustments to net income--------
Net income before extra. items6599
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6599
Inc. avail. to common incl. extra. items6599
Diluted net income6599
Dilution adjustment------0
Diluted weighted average shares43424242
Diluted EPS excluding extraordinary itemsvalue per share0.150.130.210.21
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.150.140.210.21